-
-
-
-
-
-
-
Travere Therapeutics (TVTX) Tops Q3 EPS by 88c
-
-
-
-
-
-
-
Travere Therapeutics Reports First Quarter 2025 Financial Results
-
-
-
-
-
-
-
Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance
-
-
-
-
-
-
-
Ligand Reports First Quarter 2024 Financial Results
-
-
-
-
-
-
-
Travere Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
-
-
-
-
-
-
-
Ligand Reports Second Quarter 2023 Financial Results
-
-
-
-
-
-
-
Travere Therapeutics to Report First Quarter 2023 Financial Results
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

